TERN vs WMT · $6.12B cap vs P/E 42, rev $713.16B
Terns Pharmaceuticals Inc (TERN) versus Walmart Inc (WMT) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Walmart Inc (WMT) is a discount stores company listed on US. It is led by Doug McMillon.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported WMT revenue for 2026-01-31 was $713.16B. Net income was $21.89B. Revenue was up 4.7% from 2025-01-31 to 2026-01-31. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
TERN currently screens at market cap $6.12B. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
Not investment advice. Open the TERN and WMT stock pages for the full models.
Not investment advice.